Current management of Ménière's disease in an only hearing ear.
OBJECTIVE
Ménière's disease in an only hearing ear is rare. Our objective is to define the current practice patterns for this problem.


METHODS
Clinically active members of the American Otological Society and the American Neurotology Society.


METHODS
Survey responses.


RESULTS
Three hundred fifty-four surveys were sent out, and 165 were returned (48%). Ninety-nine percent recommended dietary modification as first line. Only 39% recommended oral corticosteroids. Second-line treatments were, in order of significance, the Meniett device (Medtronic ENT, Jacksonville, FL, USA), intratympanic corticosteroids, endolymphatic mastoid shunt, intratympanic gentamicin, and endolymphatic sac vein decompression. Interestingly, 71.5% of respondents would operate on an only hearing ear provided the appropriate circumstances.


CONCLUSIONS
We have documented current practice patterns for treatment. Second-line treatments vary, but the Meniett is recommended most frequently, and further recommendations may not logically progress from least to most invasive. Many respondents eventually offer surgery.
Peterson
William M
WM
Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Penn State Milton S. Hershey Medical Center, Hershey, PA 17033, USA.
Isaacson
Jon E
JE
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D019299:Decompression, Surgical; D004712:Endolymphatic Sac / Q000601:surgery; D005247:Feeding Behavior; D005839:Gentamicins / Q000627:therapeutic use; D046088:Hearing Loss, Unilateral / Q000453:epidemiology*; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D008575:Meniere Disease / Q000150:complications* / Q000628:therapy*; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011795:Surveys and Questionnaires
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D005839:Gentamicins